Cargando…
Immune checkpoint inhibition: prospects for prevention and therapy of hepatocellular carcinoma
The global prevalence of liver cancer is rapidly rising, mostly as a result of the amplified incidence rates of viral hepatitis, alcohol abuse and obesity in recent decades. Treatment options for liver cancer are remarkably limited with sorafenib being the gold standard for advanced, unresectable he...
Autores principales: | Elsegood, Caryn L, Tirnitz-Parker, Janina EE, Olynyk, John K, Yeoh, George CT |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704099/ https://www.ncbi.nlm.nih.gov/pubmed/29326816 http://dx.doi.org/10.1038/cti.2017.47 |
Ejemplares similares
-
Transdifferentiation of pancreatic progenitor cells to hepatocyte-like cells is not serum-dependent when facilitated by extracellular matrix proteins
por: Gratte, Francis D., et al.
Publicado: (2018) -
TWEAK and LTβ Signaling during Chronic Liver Disease
por: Dwyer, Benjamin J., et al.
Publicado: (2014) -
Current progress and prospect of immune checkpoint inhibitors in hepatocellular carcinoma
por: Zeng, Zhu, et al.
Publicado: (2020) -
Immune checkpoint inhibitor therapy for hepatocellular carcinoma
por: Ramai, Daryl, et al.
Publicado: (2022) -
Current Evidence for Immune Checkpoint Inhibition in Advanced Hepatocellular Carcinoma
por: Foy, Victoria, et al.
Publicado: (2023)